The Impact of Interscalene Brachial Plexus Blockade on Postoperative Function after Shoulder Surgery - Interscalene block

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2010-021224-10-AT

Enrollment

Registered

2010-08-02

Start date

2010-09-02

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The impact of interscalene brachial plexus blockade on postoperative function after shoulder surgery

Interventions

Trade Name: Naropin Product Name: Naropin Product Code: 1-21500 Pharmaceutical Form: Concentrate for solution for injection INN or Proposed INN: Ropivacaine CAS Number: 84057-95-4 Current Sponsor cod

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient scheduled for surgery of subacromiale impingement and shoulder joint arthrolysis, ASA I-II, 18-65years old, Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: pregnancy, drug abusus, coagulopathies

Design outcomes

Primary

Measure	Time frame
Main Objective: The impact of interscalene brachial plexus blockade on postoperative function after shoulder surgery;Secondary Objective: Patients satisfaction Interscalene brachial plexus dislocation rate postoperative opioid demand;Primary end point(s): differnences in postoperative shoulder mobility following passive physiotherapy according to the 3 study groups	—

Countries

Austria

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026